Cytosorbents (CTSO) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $10.00 price target on the stock.
CytoSorbents Corp (CTSO) Q4 2025 Earnings Call Highlights: Navigating Growth and Regulatory ... [Yahoo! Finance]
Cytosorbents outlines cash flow breakeven path for second half of 2026 amid international sales growth [Seeking Alpha]
CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights [Yahoo! Finance]
CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights